Collagen Matrix, which is backed by Linden Capital Partners, has named Shawn McCarthy as CEO and a member of its board of directors. Most recently, McCarthy was general manager of structural heart valves at Boston Scientific. And prior to that, he was president and CEO of Tryton Medical.
Oakland, NJ (January 28, 2020) – Collagen Matrix, Inc. is pleased to announce the appointment of Shawn McCarthy as CEO and member of the Board of Directors, effective January 27. Mr. McCarthy is an accomplished global healthcare executive with nearly 30 years of experience in medical devices, most recently serving as General Manager of Structural Heart Valves at Boston Scientific, where he was responsible for developing and launching a range of innovative and clinically significant products and acquiring key technologies.
Prior to Boston Scientific, McCarthy was President and CEO at Tryton Medical, a privately held venture-backed startup which earned the first global approval for a dedicated coronary bifurcation stent. He also held a range of management roles with increasing responsibility at Cordis, a Johnson & Johnson company, culminating as Worldwide Vice President of Marketing for Cardiology, Endovascular, and Neurovascular. Subsequent to Johnson & Johnson, McCarthy was Senior Vice President and General Manager of both the Vascular and Oncology Surgery business units at AngioDynamics. McCarthy holds a Master of Business Administration and a Bachelor of Arts in Economics from Syracuse University.
“Collagen Matrix has established itself as the premier developer and manufacturer of collagen-based medical products with world-class technological expertise, a focus on quality, and strong product development capabilities. I am honored by the opportunity to contribute to this organization and am excited to work with the talented team at Collagen Matrix,” McCarthy said.
“We are extremely fortunate to have Shawn join the Collagen Matrix team. Shawn’s deep experience and proven track record in the medical device space uniquely position him to lead the Company to continued growth,” said Jeff Nelson, Chairman of the Board and Operating Partner at Linden Capital Partners, Collagen Matrix’s majority shareholder.
About Collagen Matrix, Inc.
Collagen Matrix, Inc. is a developer and manufacturer of collagen-based medical products used for tissue and bone repair and regeneration. Founded in 1997, Collagen Matrix is headquartered in Oakland, New Jersey and develops proprietary products that are sold to OEM customers on either a contract or private label basis across orthopedic, sports medicine, dental, and neurosurgery end markets. The company also offers partnership opportunities including distribution, contract product development, and contract manufacturing services. For more information, please visit www.collagenmatrix.com.
About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on investing in the healthcare industry. Linden’s strategy is based upon three elements: i) healthcare specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms across the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit www.lindenllc.com.